World Biosimilars Conference

Meetings International is pleased to welcome you at the International Conference on biosimilars (World Biosimilars Conference ) booked amid August 20-21, 2018 in Chicago, USA. The theme for the said conference is “New Inventions in Biosimilars”. For further details about the conference please have a glance at our.webpage http://www.meetingsint.com/conferences/biosimilar

Highlights of Biosimilar 2018:

• Keynote Speech by Dr. Sarfaraz K. Niazi, Executive Chairman at Karyo Biologics, University of Illinois, United States.

• Keynote Speech by Dr. Cecil Nick, Vice President, Parexel,United States.

• Keynote Speech by Dr. Ronald P. Dudek, Lentigen Technology, Inc. United States.

• Keynote Speech by Dr. James R Harris, CEO, Healthcare Economics LLC, United States.

• Keynote speech by Dr. Milind Antani, Nishith Desai Associates,India.

• Keynote speech by Dr. Mohan Dewan |Advocate, Patent & Trademark Attorney | Principal, India

• Keynote speech by Dr. Joel I. Osorio, Chief Executive Officer / Founder, Regenerage, Mexico

• Keynote speech by Dr. matteo micucci, European Research Doctor in Pharmaceutical Sciences, Italy

• Keynote Speech by Dr. Ines Fradi, Head of Pharmacy and Medicines Directorate, Ministry of Health, Tunisia

• Keynote Speech by Dr. Yavuz S. Silay, Chairman ICG(Istanbul Consulting Group) /Director Avcılar Hospital R&D Center/Partner FasterCapital/SoPE/Rutgers Univ.

• Keynote Speech by Dr. Leandro Gabriel Mieravilla, Cassara Biotech Canada, Licensing Executives Society (Canada and USA)

• Keynote Speech by Dr. Joanna T. Brougher, Owner and Principal at BioPharma Law Group PLLC, USA

• Keynote Speech by Dr. Mark Emalfarb, Board Member and Founder at Dyadic International, Inc., USA

• Workshop by Dr. Ronald P. Dudek, Lentigen Technology, Inc. United States.

• Workshop by James M. Sulzberger, Downstream Purification Scientist, Bio-Rad Laboratories, USA

• Workshop by Dr. James R Harris, CEO, Healthcare Economics LLC.

• Oral Speech by Dr. Rafiq Islam, Senior Director, Celerion Inc, USA

• Oral Speech by Nicola Travierso, President, Presso Velit Biopharmaceuticals Austria, Austria

• Oral Speech by Dr. Aparna Kasinath, Syngene International Limited, India

• Oral Speech by Diya Chadha Manek, National Institute for Health Research (NIHR) Clinical Research Network (CRN), UK

• Oral Speech by Shimuye Kalayu Yirga, Woldia University, Ethiopia

• Oral Speech by Sandesh Warudkar, MBBS, MD (Pharmacology), Cadila Healthcare Ltd, Ahmedabad, India

• Oral Speech by Dr. Sumant Chaubey, Global Consultant and Process Expert for Biosimilars Development, CMD at 3B Biotech, India